Morphine | According to the technical date of the product, this medicine is contraindicated in patients with respiratory depression or severe obstructive respiratory disease.| The toxicological profile of morphine is similar to that of other opioid analgesics, although the effects appear more frequently. The most characteristic adverse effects are (>1/1000, <1/100): Cardiac disorders: cardiac arrest, tachycardia and bradycardia, hypertension, hypotension, intracranial hypertension, collapse.
4.3. Contraindications
It is contraindicated in:
– Patients with respiratory depression or severe obstructive respiratory disease.
Risk of concomitant use of sedative drugs, such as benzodiazepines or other related drugs:
Concomitant use of Morphine B. Braun 1 mg/ml solution for injection and sedatives such as benzodiazepines or other related drugs may cause sedation, respiratory depression, coma and death. Due to these risks, the concomitant prescription of these sedating drugs should be reserved for patients for whom there are no other alternative treatment options.
4.8. Adverse reactions
The toxicological profile of morphine is similar to that of other opioid analgesics, although the effects appear more frequently. The most characteristic side effects are:
– Uncommon (>1/1000, <1/100):
Cardiac disorders: cardiac arrest, tachycardia and bradycardia, hypertension, hypotension, intracranial hypertension, collapse;